# Implementation plan: Operational Assurance Excellence

## Phase 1 - Compatibility, coverage, and mutation cohorts

- [x] Task: Add failing current, N-1, and incompatible consumer-matrix tests.
- [x] Task: Enforce critical-module and changed-line branch coverage.
- [x] Task: Add cohort-aware mutation evidence and promotion validation.
- [x] Task: Phase verification and checkpoint.

## Phase 2 - Reproducibility and performance statistics

- [x] Task: Add failing independent-builder digest comparison tests.
- [x] Task: Add Linux/Windows normalized build evidence and comparator.
- [x] Task: Add runner fingerprints, repeated samples, and confidence-interval ratchets.
- [x] Task: Phase verification and checkpoint.

## Phase 3 - Collector privacy and scientific oracles

- [x] Task: Add ephemeral collector export and privacy/correlation tests.
- [x] Task: Add boundary, near-tie, tail, and higher-dimensional reference cases.
- [x] Task: Extend cross-backend and available-binding conformance.
- [x] Task: Phase verification and checkpoint.

## Phase 4 - Cross-repository closeout

- [x] Task: Run complete local and hosted quality, security, mutation, build, and profile suites.
- [x] Task: Complete independent principal reviews and remediate findings.
- [x] Task: Synchronize C15 issue and Project evidence while retaining human gates.
- [x] Task: Phase verification and checkpoint.

## Completion evidence

- VOIAGE implementation head `51825775a2491fd3dae572a5dadd152a4576f444`:
  Operational Assurance `29702890410`, cross-platform assurance `29702890390`,
  all six polyglot bindings `29702890378`, CodeQL `29702890379`, SBOM
  `29702890389`, dependency assurance `29702890395`, dependency review
  `29702890400`, action audit `29702890391`, benchmark tracking `29702890383`,
  and pre-silicon evidence `29702890422` passed.
- Expensive CI `29703045822` passed profiling, coverage, unit, integration, E2E,
  typing, security, documentation, dynamic-version, frontier-contract, and
  benchmark gates. Critical mutation killed 40/40 and the complete 65-mutant
  cohort killed 51 (78.462%; absolute debt 14; density 0.215385).
- The aggregate remains intentionally red until a human reviewer approves
  baseline digest
  `57ada2fe8af00987eb9df22b2d41494b6d3d2bfa11e63b42422e0932ec23d4f1`.
- Independent principal review found no remaining Critical, High, or Medium
  implementation defect. Merge, mutation-baseline promotion, release,
  publication, and issue closure remain human gates.
